Skip to Content Facebook Feature Image

Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026

Business

Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026
Business

Business

Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026

2026-01-26 20:00 Last Updated At:20:15

SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- Divamics (DIVAMICS), an AI-driven biotechnology company specializing in high-precision molecular discovery, highlighted the significant advancement of its internal pipeline during the Biotech Showcase™ at JPM Week 2026. The company provided updated milestones for its lead autoimmune program, DVI-001, and announced the first disclosure of DVI-004, a promising new metabolic disease program generated by its proprietary AI platform. The presentation centered on Divamics' ability to bridge the gap between AI-driven prediction and clinical-ready assets.

A Foundation in Molecular Excellence

Founded in 2021, Divamics is led by a founding team with deep roots in the global computational chemistry community. CEO Dr. John Zheng and Dr. Hao Liu both earned their Ph.D.s from the University of Florida, training within the prestigious AMBER molecular dynamics ecosystem.

During his tenure in the U.S., Dr. Zheng pioneered the MovableType free energy algorithm, which secured a second-place global ranking in the SAMPL6 blind drug design challenge and earned commendation from Nobel Laureate Roald Hoffmann. The technology's industrial viability was further validated through its commercial integration by QuantumBio. This academic rigor is complemented by Dr. Liu's extensive experience at Genentech, where she specialized in large-scale data architecture—a critical pillar for Divamics' AI-driven insights.

The company's scientific strategy is guided by Dr. Kenneth M. Merz Jr., Chief Scientific Advisor and a world-renowned authority in computational chemistry, ensuring that Divamics remains at the forefront of molecular simulation technology.

Market Validation and Strategic Global Footprint

Divamics' technological prowess is backed by strong commercial momentum. At the Showcase, the company highlighted its ongoing collaboration with BrightGene, which recently resulted in peer-reviewed research published in the Journal of Medicinal Chemistry (2025). The market's interest in Divamics' platform was further evidenced by more than 50 high-level partnering meetings with global biopharma stakeholders during JPM Week.

"JPM Week is the ideal stage to share our progress with the global life sciences community," said Dr. John Zheng, Founder and CEO of Divamics. "By combining our U.S.-trained scientific expertise with China's robust and agile biotech infrastructure, we offer global partners a unique value proposition: high-precision molecular discovery delivered with exceptional capital efficiency and executional speed."

Divamics operates with a strategic global footprint, including its headquarters in Suzhou, operational teams in Shanghai and Beijing, and a Singapore hub dedicated to fostering international R&D collaborations.

About Divamics

Divamics is an AI-driven biotech company dedicated to bringing molecular precision to early-stage R&D. By integrating physics-based molecular dynamics with machine learning, Divamics accelerates the transition from hit identification to preclinical candidate selection. The company offers both collaborative R&D services and a growing internal pipeline of partner-ready assets.

Media Contact: Divamics, Marketing Department, marketing@divamics.com 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026

Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026

SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- Global fintech company WireBarley has announced a multi-year strategic partnership with Los Angeles Football Club (LAFC), becoming the club's Official Remittance Partner and the first Korean fintech company to partner with a Major League Soccer team.

The collaboration unites two brands built on global connectivity, trust, and community. As one of Major League Soccer's most internationally recognized clubs, LAFC embodies the diverse, global culture of Los Angeles—an identity that closely aligns with WireBarley's mission to make cross-border money transfers more accessible, transparent, and reliable for people around the world.

WireBarley specializes in connecting customers across Asia-Pacific markets—including Korea, Australia, New Zealand, Hong Kong SAR, and Vietnam—with North America. Now through its LAFC partnership, the company aims to build stronger connections with Asian American communities in the U.S. while gaining visibility among the team's globally connected fans.

As part of the partnership, WireBarley will receive marketing rights within Los Angeles and designated international territories, along with digital and social integrations designed to engage fans through compelling content, sweepstakes, and matchday experiences. The collaboration will emphasize shared values of innovation, inclusivity, and global perspective—core pillars for both organizations.

"We are extremely excited to partner with WireBarley given their focus on connecting people from various countries and spanning different cultures," said LAFC Co-President Larry Freedman. "Playing in Los Angeles, a city that serves as one of the most globally connected cities in the world, this was a natural fit as we seek to reflect the identity of our fanbase."

The partnership further strengthens LAFC's growing portfolio of international and technology-driven partners, reinforcing the club's position at the intersection of sport, culture, and global community. 

"We are honored to partner with LAFC, a club renowned for its excellence and dedication to fans," John Joongwon Yoo, CEO and Co-founder of WireBarley. "This partnership extends beyond the pitch to connect communities and create meaningful experiences. It will bring fans in Los Angeles and our global customers in countries including Korea, Australia, and beyond closer to LAFC through engaging matchday and interactive online experiences that celebrate the club's spirit and passion."

WireBarley provides international remittance services across 46 countries, with operations in seven key markets: Korea, the U.S., Canada, Australia, New Zealand, Vietnam, and Hong Kong SAR (temporarily suspended). The company has recorded over 2.2 million app downloads and 1.1 million registered users worldwide, establishing itself as a leading digital remittance platform in the Asia-Pacific region.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

WireBarley Partners with LAFC in First Deal for Korean Fintech

WireBarley Partners with LAFC in First Deal for Korean Fintech

Recommended Articles